Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia.
CAS Number:
[1407495-02-6]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted